Successful treatment of multidrug resistant Acinetobacter baumannii meningitis | Zendy

Suzan Saçar | Zendy; Hüseyin Turgut | Zendy; Derya Hırçın Cenger | Zendy; Erdal Çoşkun | Zendy; Ali Aşan | Zendy; İlknur Kaleli̇ | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Successful treatment of multidrug resistant Acinetobacter baumannii meningitis

Author(s) -

Suzan Saçar,

Hüseyin Turgut,

Derya Hırçın Cenger,

Erdal Çoşkun,

Ali Aşan,

İlknur Kaleli̇

Publication year - 2007

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.376

Subject(s) - meropenem , acinetobacter baumannii , medicine , multiple drug resistance , meningitis , antimicrobial , acinetobacter , microbiology and biotechnology , intensive care medicine , drug resistance , antibiotics , antibiotic resistance , biology , pediatrics , pseudomonas aeruginosa , bacteria , genetics

Acinetobacter baumannii is a major cause of nosocomial infections in many hospitals and appears to have a propensity for developing multiple antimicrobial resistance rapidly.We report two cases with post-surgical meningitis due to multidrug resistant A. baumannii which were successfully treated with high-dose intravenous meropenem therapy.Multidrug resistant Acinetobacter spp. in intensive care units are a growing concern. High-dose meropenem is used in the treatment of these infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research